{"pmid":32352363,"title":"Egypt's groundwork blessing during the COVID-19 pandemic curse: Rheumatologic experience.","text":["Egypt's groundwork blessing during the COVID-19 pandemic curse: Rheumatologic experience.","Eur J Rheumatol","Gheita, Tamer A","Kenawy, Sanaa A","32352363"],"journal":"Eur J Rheumatol","authors":["Gheita, Tamer A","Kenawy, Sanaa A"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352363","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.5152/eurjrheum.2020.2058","locations":["Egypt"],"countries":["Egypt"],"countries_codes":["EGY|Egypt"],"topics":["Prevention"],"weight":1,"_version_":1666138495636209665,"score":9.490897,"similar":[{"pmid":32334164,"pmcid":"PMC7169881","title":"COVID-19 pandemic and environmental pollution: A blessing in disguise?","text":["COVID-19 pandemic and environmental pollution: A blessing in disguise?","In late 2019, a novel infectious disease with human to human transmission (COVID-19) was identified in Wuhan China, which now has turned into a global pandemic. Countries all over the world have implemented some sort of lockdown to slow down its infection and mitigate it. Lockdown due to COVID-19 has drastic effects on social and economic fronts. However, this lockdown also has some positive effect on natural environment. Recent data released by NASA (National Aeronautics and Space Administration) and ESA (European Space Agency) indicates that pollution in some of the epicenters of COVID-19 such as Wuhan, Italy, Spain and USA etc. has reduced up to 30%. This study compiled the environmental data released by NASA and ESA before and after the coronavirus pandemic and discusses its impact on environmental quality.","Sci Total Environ","Muhammad, Sulaman","Long, Xingle","Salman, Muhammad","32334164"],"abstract":["In late 2019, a novel infectious disease with human to human transmission (COVID-19) was identified in Wuhan China, which now has turned into a global pandemic. Countries all over the world have implemented some sort of lockdown to slow down its infection and mitigate it. Lockdown due to COVID-19 has drastic effects on social and economic fronts. However, this lockdown also has some positive effect on natural environment. Recent data released by NASA (National Aeronautics and Space Administration) and ESA (European Space Agency) indicates that pollution in some of the epicenters of COVID-19 such as Wuhan, Italy, Spain and USA etc. has reduced up to 30%. This study compiled the environmental data released by NASA and ESA before and after the coronavirus pandemic and discusses its impact on environmental quality."],"journal":"Sci Total Environ","authors":["Muhammad, Sulaman","Long, Xingle","Salman, Muhammad"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32334164","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.scitotenv.2020.138820","keywords":["covid-19","environmental pollution","no(2) emissions"],"locations":["Wuhan","China","Wuhan","Italy","Spain","USA"],"countries":["United States","Italy","China","Spain"],"countries_codes":["USA|United States","ITA|Italy","CHN|China","ESP|Spain"],"weight":0,"_version_":1666138493950099456,"score":55.69517},{"pmid":32404314,"title":"Cassandra's curse and covid-19: why do governments listen to businesses over doctors?","text":["Cassandra's curse and covid-19: why do governments listen to businesses over doctors?","BMJ","Green, Stephen T","Cladi, Lorenzo","32404314"],"journal":"BMJ","authors":["Green, Stephen T","Cladi, Lorenzo"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404314","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1136/bmj.m1852","link_comment_for":"32229543","locations":["Cassandra"],"weight":0,"_version_":1666950579777175552,"score":50.260506},{"pmid":32227493,"title":"Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.","text":["Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.","Confronting the challenge of the outbreak of COVID-19 should sharpen our focus on global drug access as a key issue in antiviral therapy testing. The testing and adoption of effective therapies for novel coronaviruses are hampered by the challenge of conducting controlled studies during a state of emergency. The access to direct antiviral drugs, such as ribavirin, that have an existing inventory and reliable supply chain may be a priority consideration for therapies developed for the 2019-nCoV infection outbreaks and any strain variants that may emerge. On the basis of the direct antiviral activity of ribavirin against 2019-nCoV in vitro and evidence for potency enhancement strategies developed during the prior SARS and MERS outbreaks, ribavirin may significantly impact our ability to end the lingering outbreaks in China and slow outbreaks in other countries. The apparent COVID-19 pandemic provides an opportunity to follow dosage guidelines for treatment with ribavirin, test new therapeutic concepts, and conduct controlled testing to apply the scientific rigor required to address the controversy around this mainstay of antiviral therapy.","J Med Virol","Khalili, Jahan S","Zhu, Hai","Mak, Nga Sze Amanda","Yan, Yongqi","Zhu, Yi","32227493"],"abstract":["Confronting the challenge of the outbreak of COVID-19 should sharpen our focus on global drug access as a key issue in antiviral therapy testing. The testing and adoption of effective therapies for novel coronaviruses are hampered by the challenge of conducting controlled studies during a state of emergency. The access to direct antiviral drugs, such as ribavirin, that have an existing inventory and reliable supply chain may be a priority consideration for therapies developed for the 2019-nCoV infection outbreaks and any strain variants that may emerge. On the basis of the direct antiviral activity of ribavirin against 2019-nCoV in vitro and evidence for potency enhancement strategies developed during the prior SARS and MERS outbreaks, ribavirin may significantly impact our ability to end the lingering outbreaks in China and slow outbreaks in other countries. The apparent COVID-19 pandemic provides an opportunity to follow dosage guidelines for treatment with ribavirin, test new therapeutic concepts, and conduct controlled testing to apply the scientific rigor required to address the controversy around this mainstay of antiviral therapy."],"journal":"J Med Virol","authors":["Khalili, Jahan S","Zhu, Hai","Mak, Nga Sze Amanda","Yan, Yongqi","Zhu, Yi"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227493","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25798","keywords":["covid-19","novel coronavirus","ribavirin"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Ribavirin"],"topics":["Treatment"],"weight":1,"_version_":1666138492431761410,"score":47.798622},{"pmid":32353346,"pmcid":"PMC7185947","title":"Estimation of COVID-19 burden in Egypt.","text":["Estimation of COVID-19 burden in Egypt.","Lancet Infect Dis","Hassany, Mohamed","Abdel-Razek, Wael","Asem, Noha","AbdAllah, Mohamed","Zaid, Hala","32353346"],"journal":"Lancet Infect Dis","authors":["Hassany, Mohamed","Abdel-Razek, Wael","Asem, Noha","AbdAllah, Mohamed","Zaid, Hala"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32353346","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/S1473-3099(20)30319-4","locations":["Egypt"],"countries":["Egypt"],"countries_codes":["EGY|Egypt"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1666138495627821056,"score":42.361965},{"pmid":32353348,"pmcid":"PMC7185946","title":"Estimation of COVID-19 burden in Egypt.","text":["Estimation of COVID-19 burden in Egypt.","Lancet Infect Dis","Sahmoud, Tarek","32353348"],"journal":"Lancet Infect Dis","authors":["Sahmoud, Tarek"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32353348","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/S1473-3099(20)30318-2","locations":["Egypt"],"countries":["Egypt"],"countries_codes":["EGY|Egypt"],"weight":0,"_version_":1666138495627821057,"score":42.361965}]}